Brooklands Fund Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3
Closed -$17.1K 81
2025
Q4
$17.1K Buy
+3
New +$1.01K 0.01% 74

Other funds holding ELV

Brooklands Fund Management's ELV Position: Q1 2026 in Review

Brooklands Fund Management increased its Elevance Health (ELV) stake by 1,055,250% in Q1 2026, buying an estimated $6.94M and bringing the position to 21,107 shares worth $6.2M. The position accounts for 6.97% of the portfolio, ranked #3.

Brooklands Fund Management first reported a position in ELV in Q4 2025 and has held it in 2 quarters since. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Brooklands Fund Management held 21,107 shares of Elevance Health worth $6.2M as of Q1 2026.
  • Brooklands Fund Management bought 21,105 Elevance Health shares in Q1 2026, an estimated $6.94M.
  • Elevance Health made up 6.97% of Brooklands Fund Management's portfolio in Q1 2026, its #3 holding.
  • Brooklands Fund Management first reported a position in Elevance Health in Q4 2025 and has held it in 2 quarters since.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Brooklands Fund Management's 13F filing for Q1 2026, filed 14 May 2026.